finanzen.net
16.09.2019 13:00
Bewerten
(0)

Clean, Marine-sourced Tripeptide Collagen Hits US Market

LANDING, New Jersey, Sept. 16, 2019 /PRNewswire/ -- MoriKol, a naturally derived, marine-based tripeptide collagen ingredient from kosher, warm-water fish makes its debut in the US. The ingredient is a clean-label, consumer friendly alternative to bovine and porcine collagen. Through a pioneering licensing deal, Dolcas makes this uniquely efficacious "beauty-from-within" ingredient available to US consumers at a low, clinically supported daily dose of just 1 g. Morikol will be featured at this year's SSW Expo in Las Vegas, booth #6675.

Clean, Marine-Sourced Tripeptide Collagen Hits US Market

MoriKol's proprietary processing method results in a flavorless, odorless, highly pure product that is water- and temperature-stable for use in diverse applications. Unlike traditional collagen ingredients, MoriKol's small, freely absorbable collagen peptides are of very low molecular weight (a 15% tripeptide standard), which allows for a low dosing of the ingredient. Coupled with its convenient capsule delivery format that does not exist in other collagens on the market, MoriKol is a highly bioavailable, more bioactive collagen.

"Collagen is the most abundant protein type in the human body," enthuses Shavon Jackson-Michel, ND, Director of Medical & Scientific Affairs at DolCas. "Supplemental collagen's potential whole-body application, including "beauty from within," joint health, sports performance, and cardiovascular and digestive system support is far-reaching."

Even as popularity of hydrolyzed collagen products has grown at an impressive scale, a 2019 report by the Grand View Research firm notes that the convention of low bioavailability land animal-sourced collagen — with acknowledged risks of transmittable diseases like Bovine Spongiform Encephalopathy (BSE), or Mad Cow Disease, and Foot-and-mouth disease (FMD) — still prevail over more appealing marine sources because of the cost differential. MoriKol closes that differential with its unique beauty-from-within collagen preparation that delivers a concentrated dose of highly absorbable peptides.

The Tripeptide Advantage

The novel processing of MoriKol delivers a minimum of 15% of readily utilizable forms of peptides that are absorbed intact. MoriKol also guarantees the delivery of the specific amino acid sequence integral to collagen's structure, glycine-proline-hydroxyproline (GPH), and showing 3% GPH on assay.

"This is a completely novel ingredient," emphasizes Jackson-Michel. "No US-marketed fish collagen has quantified collagen actives at this level of specificity. Many commercially available collagen hydrolysates available collagen hydrolysates require doses between 2.5-10g/day, but offer negligible quantities of bioavailable peptides. Bi- and tripeptides are the smallest absorbable units of collagen, and when provided in a finite amount, provide greater potential for restorative functions, including fibroblast recruitment to damaged areas and collagen formation from bioavailable building blocks."

MoriKol delivers nearly 15 times the amount of intact-absorbed bioactives compared to other collagen brands. This allows for unprecedented low dosage levels of just 1g/day, with comparably shorter clinical effect times. "MoriKol's low dosing avails itself to compact, convenient delivery forms, such as capsules or gummies, and not just powders," Jackson-Michel concludes.

A Warm-Water Edge

"Piscine-sourced collagen products are known for their smaller molecular weights compared to porcine and bovine sources, but even with fish, warm water-sourced marine collagen is believed to have better biocompatibility than cold water options such as salmon and cod, delivering higher levels of the amino acids proline and hydroxyproline — the two essential building blocks of collagen." explains Jackson-Michel.

MoriKol's controlled manufacturing produces a consistent product that is held to rigorous breeding, cultivation, and processing standards. MoriKol's high purity is supported by its clearance of 40+ veterinarian and piscine-specific drug tests, including those for antibiotics, dioxins, PCBs and hormones. MoriKol's quality further extends to a low heavy metal profile, meeting stringent Prop-65 specifications.

Alongside MoriKol, DolCas will showcase four other new, clinically studied ingredient innovations at this year's SSW Vegas show. Curcugen, the industry's next-generation curcumin with a food-state profile; Bergacyn®, targeting fatty liver and supporting healthy metabolism; TruOliv, a unique synergistic, whole food olive extract; and Fortiquin, an innovative sexual health product for men.

References available upon request 

Visit us at SSW Expo in Las Vegas, booth #6675.

 

For more information, contact:

Company contact:

Press Contact:

DolCas Biotech, LLC

NutriPR

Shavon Jackson-Michel, ND

Liat Simha

Director of Medical & Scientific Affairs

Tel: +972-9-9742893

Tel: 973-347-1958 ext. 217

E-mail: liat@nutripr.com

Email: info@dolcas-biotech.com

Website: www.nutripr.com

Web: www.dolcas-biotech.com

Twitter: @LiatSimha

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/clean-marine-sourced-tripeptide-collagen-hits-us-market-300918488.html

SOURCE DolCas Biotech

So folgen Sie Trends!

Anleger, die ohne Stra­tegie handeln, über­leben nicht lange am Markt. Die Trend­folge­stra­tegie gilt als eine der erfolg­reichsten Stra­tegien überhaupt. Wie Sie Trends früh­zeitig erkennen und wie Sie so deut­sche Aktien handeln, erfah­ren Sie im Online-Seminar. Jetzt kostenlos anmelden!
Werbung
Werbung
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

Dow schwächer erwartet -- DAX etwas höher -- Bank of America mit Gewinneinbruch -- Wirecard weist Vorwürfe zurück -- Gewinnwarnung bei WACKER CHEMIE -- ASML, K+S, Beiersdorf, Infineon im Fokus

IT-Probleme legen Produktion bei Porsche zeitweise lahm. Machtkampf bei Ceconomy eskaliert - Chef vor dem Abgang. ASOS-Aktien springen nach Zahlen hoch. EU will angeblich kartellrechtliche Maßnahmen gegen Broadcom einleiten. Pharmakonzern Roche hebt Jahresprognose erneut an. United Airlines hebt Jahresziele trotz 737-Max-Krise an.

Die 5 beliebtesten Top-Rankings

In diesen Berufen bekommt man das höchste Gehalt
Mit welchem Beruf kommt man am ehesten an die Spitze?
Big-Mac-Index
In welchen Ländern kostet der Big Mac wie viel?
Das sind die bestbezahlten Schauspieler 2019
Wer verdiente am meisten?
Die Performance der Rohstoffe in in Q3 2019.
Welcher Rohstoff macht das Rennen?
Die Performance der TecDAX-Werte in Q3 2019.
Welche Aktie macht das Rennen?
mehr Top Rankings

Umfrage

Die Bundesregierung erlaubt anscheinend Huawei-Technik bei Aufbau des 5G-Netzes. Was halten Sie davon?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Deutsche Bank AG514000
Daimler AG710000
NEL ASAA0B733
Volkswagen (VW) AG Vz.766403
Amazon906866
Microsoft Corp.870747
Apple Inc.865985
Infineon AG623100
Aurora Cannabis IncA12GS7
BASFBASF11
CommerzbankCBK100
BayerBAY001
Deutsche Telekom AG555750
TUITUAG00